 | • レポートコード：GIR-2104Z01037 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、抗ウイルス薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗ウイルス薬の種類別市場規模（ヌクレオチドポリメラーゼ阻害剤、逆転写酵素阻害剤、プロテアーゼ阻害剤）、用途別市場規模（HIV、肝炎、HSV、インフルエンザ）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・抗ウイルス薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：F. Hoffmann-La Roche、GlaxoSmithKline、Bristol-Myers-Squibb、AbbVie、Johnson & Johnson、Merck & Co、Aurobindo Pharma、Cipla、Dr Reddy’s ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ヌクレオチドポリメラーゼ阻害剤、逆転写酵素阻害剤、プロテアーゼ阻害剤 ・用途別分析2016年-2026年：HIV、肝炎、HSV、インフルエンザ ・抗ウイルス薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・抗ウイルス薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・抗ウイルス薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・抗ウイルス薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・抗ウイルス薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Anti-Viral Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Anti-Viral Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Anti-Viral Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Anti-Viral Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Nucleotide Polymerase Inhibitor
Reverse Transcriptase Inhibitor
Protease Inhibitor
Market segment by Application can be divided into
HIV
Hepatitis
HSV
Influenza
The key market players for global Anti-Viral Drugs market are listed below:
F. Hoffmann-La Roche
GlaxoSmithKline
Bristol-Myers-Squibb
AbbVie
Johnson & Johnson
Merck & Co
Aurobindo Pharma
Cipla
Dr Reddy’s
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Anti-Viral Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-Viral Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Nucleotide Polymerase Inhibitor
1.2.3 Reverse Transcriptase Inhibitor
1.2.4 Protease Inhibitor
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-Viral Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 HIV
1.3.3 Hepatitis
1.3.4 HSV
1.3.5 Influenza
1.4 Global Anti-Viral Drugs Market Size & Forecast
1.4.1 Global Anti-Viral Drugs Sales in Value (2016-2026))
1.4.2 Global Anti-Viral Drugs Sales in Volume (2016-2026)
1.4.3 Global Anti-Viral Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Anti-Viral Drugs Production Capacity Analysis
1.5.1 Global Anti-Viral Drugs Total Production Capacity (2016-2026)
1.5.2 Global Anti-Viral Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti-Viral Drugs Market Drivers
1.6.2 Anti-Viral Drugs Market Restraints
1.6.3 Anti-Viral Drugs Trends Analysis
2 Manufacturers Profiles
2.1 F. Hoffmann-La Roche
2.1.1 F. Hoffmann-La Roche Details
2.1.2 F. Hoffmann-La Roche Major Business
2.1.3 F. Hoffmann-La Roche Anti-Viral Drugs Product and Services
2.1.4 F. Hoffmann-La Roche Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Anti-Viral Drugs Product and Services
2.2.4 GlaxoSmithKline Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Bristol-Myers-Squibb
2.3.1 Bristol-Myers-Squibb Details
2.3.2 Bristol-Myers-Squibb Major Business
2.3.3 Bristol-Myers-Squibb Anti-Viral Drugs Product and Services
2.3.4 Bristol-Myers-Squibb Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 AbbVie
2.4.1 AbbVie Details
2.4.2 AbbVie Major Business
2.4.3 AbbVie Anti-Viral Drugs Product and Services
2.4.4 AbbVie Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Anti-Viral Drugs Product and Services
2.5.4 Johnson & Johnson Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Merck & Co
2.6.1 Merck & Co Details
2.6.2 Merck & Co Major Business
2.6.3 Merck & Co Anti-Viral Drugs Product and Services
2.6.4 Merck & Co Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Aurobindo Pharma
2.7.1 Aurobindo Pharma Details
2.7.2 Aurobindo Pharma Major Business
2.7.3 Aurobindo Pharma Anti-Viral Drugs Product and Services
2.7.4 Aurobindo Pharma Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Cipla
2.8.1 Cipla Details
2.8.2 Cipla Major Business
2.8.3 Cipla Anti-Viral Drugs Product and Services
2.8.4 Cipla Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Dr Reddy’s
2.9.1 Dr Reddy’s Details
2.9.2 Dr Reddy’s Major Business
2.9.3 Dr Reddy’s Anti-Viral Drugs Product and Services
2.9.4 Dr Reddy’s Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Anti-Viral Drugs Sales by Manufacturer
3.1 Global Anti-Viral Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Anti-Viral Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Anti-Viral Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Anti-Viral Drugs Manufacturer Market Share
3.4.2 Top 6 Anti-Viral Drugs Manufacturer Market Share
3.5 Global Anti-Viral Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Anti-Viral Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anti-Viral Drugs Market Size by Region
4.1.1 Global Anti-Viral Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Anti-Viral Drugs Revenue by Region (2016-2026)
4.2 North America Anti-Viral Drugs Revenue (2016-2026)
4.3 Europe Anti-Viral Drugs Revenue (2016-2026)
4.4 Asia-Pacific Anti-Viral Drugs Revenue (2016-2026)
4.5 South America Anti-Viral Drugs Revenue (2016-2026)
4.6 Middle East and Africa Anti-Viral Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Anti-Viral Drugs Sales in Volume by Type (2016-2026)
5.2 Global Anti-Viral Drugs Revenue by Type (2016-2026)
5.3 Global Anti-Viral Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Anti-Viral Drugs Sales in Volume by Application (2016-2026)
6.2 Global Anti-Viral Drugs Revenue by Application (2016-2026)
6.3 Global Anti-Viral Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Anti-Viral Drugs Sales by Type (2016-2026)
7.2 North America Anti-Viral Drugs Sales by Application (2016-2026)
7.3 North America Anti-Viral Drugs Market Size by Country
7.3.1 North America Anti-Viral Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Anti-Viral Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Anti-Viral Drugs Sales by Type (2016-2026)
8.2 Europe Anti-Viral Drugs Sales by Application (2016-2026)
8.3 Europe Anti-Viral Drugs Market Size by Country
8.3.1 Europe Anti-Viral Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Anti-Viral Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Anti-Viral Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Anti-Viral Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Anti-Viral Drugs Market Size by Region
9.3.1 Asia-Pacific Anti-Viral Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Anti-Viral Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Anti-Viral Drugs Sales by Type (2016-2026)
10.2 South America Anti-Viral Drugs Sales by Application (2016-2026)
10.3 South America Anti-Viral Drugs Market Size by Country
10.3.1 South America Anti-Viral Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Anti-Viral Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anti-Viral Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Anti-Viral Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Anti-Viral Drugs Market Size by Country
11.3.1 Middle East & Africa Anti-Viral Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Anti-Viral Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Anti-Viral Drugs Typical Distributors
12.3 Anti-Viral Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Anti-Viral Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Anti-Viral Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 4. F. Hoffmann-La Roche Major Business
Table 5. F. Hoffmann-La Roche Anti-Viral Drugs Product and Services
Table 6. F. Hoffmann-La Roche Anti-Viral Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline Major Business
Table 9. GlaxoSmithKline Anti-Viral Drugs Product and Services
Table 10. GlaxoSmithKline Anti-Viral Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bristol-Myers-Squibb Basic Information, Manufacturing Base and Competitors
Table 12. Bristol-Myers-Squibb Major Business
Table 13. Bristol-Myers-Squibb Anti-Viral Drugs Product and Services
Table 14. Bristol-Myers-Squibb Anti-Viral Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. AbbVie Basic Information, Manufacturing Base and Competitors
Table 16. AbbVie Major Business
Table 17. AbbVie Anti-Viral Drugs Product and Services
Table 18. AbbVie Anti-Viral Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 20. Johnson & Johnson Major Business
Table 21. Johnson & Johnson Anti-Viral Drugs Product and Services
Table 22. Johnson & Johnson Anti-Viral Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Merck & Co Basic Information, Manufacturing Base and Competitors
Table 24. Merck & Co Major Business
Table 25. Merck & Co Anti-Viral Drugs Product and Services
Table 26. Merck & Co Anti-Viral Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 28. Aurobindo Pharma Major Business
Table 29. Aurobindo Pharma Anti-Viral Drugs Product and Services
Table 30. Aurobindo Pharma Anti-Viral Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Cipla Basic Information, Manufacturing Base and Competitors
Table 32. Cipla Major Business
Table 33. Cipla Anti-Viral Drugs Product and Services
Table 34. Cipla Anti-Viral Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Dr Reddy’s Basic Information, Manufacturing Base and Competitors
Table 36. Dr Reddy’s Major Business
Table 37. Dr Reddy’s Anti-Viral Drugs Product and Services
Table 38. Dr Reddy’s Anti-Viral Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Anti-Viral Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 40. Global Anti-Viral Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Anti-Viral Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Anti-Viral Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Anti-Viral Drugs Production Site of Key Manufacturer
Table 44. Global Anti-Viral Drugs Sales by Region (2016-2021e) & (K Units)
Table 45. Global Anti-Viral Drugs Sales by Region (2021-2026) & (K Units)
Table 46. Global Anti-Viral Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 47. Global Anti-Viral Drugs Revenue by Region (2021-2026) & (USD Million)
Table 48. Global Anti-Viral Drugs Sales by Type (2016-2021e) & (K Units)
Table 49. Global Anti-Viral Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Global Anti-Viral Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 51. Global Anti-Viral Drugs Revenue by Type (2021-2026) & (USD Million)
Table 52. Global Anti-Viral Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 53. Global Anti-Viral Drugs Price by Type (2021-2026) & (USD/Unit)
Table 54. Global Anti-Viral Drugs Sales by Application (2016-2021e) & (K Units)
Table 55. Global Anti-Viral Drugs Sales by Application (2021-2026) & (K Units)
Table 56. Global Anti-Viral Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 57. Global Anti-Viral Drugs Revenue by Application (2021-2026) & (USD Million)
Table 58. Global Anti-Viral Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 59. Global Anti-Viral Drugs Price by Application (2021-2026) & (USD/Unit)
Table 60. North America Anti-Viral Drugs Sales by Country (2016-2021e) & (K Units)
Table 61. North America Anti-Viral Drugs Sales by Country (2021-2026) & (K Units)
Table 62. North America Anti-Viral Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 63. North America Anti-Viral Drugs Revenue by Country (2021-2026) & (USD Million)
Table 64. North America Anti-Viral Drugs Sales by Type (2016-2021e) & (K Units)
Table 65. North America Anti-Viral Drugs Sales by Type (2021-2026) & (K Units)
Table 66. North America Anti-Viral Drugs Sales by Application (2016-2021e) & (K Units)
Table 67. North America Anti-Viral Drugs Sales by Application (2021-2026) & (K Units)
Table 68. Europe Anti-Viral Drugs Sales by Country (2016-2021e) & (K Units)
Table 69. Europe Anti-Viral Drugs Sales by Country (2021-2026) & (K Units)
Table 70. Europe Anti-Viral Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 71. Europe Anti-Viral Drugs Revenue by Country (2021-2026) & (USD Million)
Table 72. Europe Anti-Viral Drugs Sales by Type (2016-2021e) & (K Units)
Table 73. Europe Anti-Viral Drugs Sales by Type (2021-2026) & (K Units)
Table 74. Europe Anti-Viral Drugs Sales by Application (2016-2021e) & (K Units)
Table 75. Europe Anti-Viral Drugs Sales by Application (2021-2026) & (K Units)
Table 76. Asia-Pacific Anti-Viral Drugs Sales by Region (2016-2021e) & (K Units)
Table 77. Asia-Pacific Anti-Viral Drugs Sales by Region (2021-2026) & (K Units)
Table 78. Asia-Pacific Anti-Viral Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 79. Asia-Pacific Anti-Viral Drugs Revenue by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Anti-Viral Drugs Sales by Type (2016-2021e) & (K Units)
Table 81. Asia-Pacific Anti-Viral Drugs Sales by Type (2021-2026) & (K Units)
Table 82. Asia-Pacific Anti-Viral Drugs Sales by Application (2016-2021e) & (K Units)
Table 83. Asia-Pacific Anti-Viral Drugs Sales by Application (2021-2026) & (K Units)
Table 84. South America Anti-Viral Drugs Sales by Country (2016-2021e) & (K Units)
Table 85. South America Anti-Viral Drugs Sales by Country (2021-2026) & (K Units)
Table 86. South America Anti-Viral Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 87. South America Anti-Viral Drugs Revenue by Country (2021-2026) & (USD Million)
Table 88. South America Anti-Viral Drugs Sales by Type (2016-2021e) & (K Units)
Table 89. South America Anti-Viral Drugs Sales by Type (2021-2026) & (K Units)
Table 90. South America Anti-Viral Drugs Sales by Application (2016-2021e) & (K Units)
Table 91. South America Anti-Viral Drugs Sales by Application (2021-2026) & (K Units)
Table 92. Middle East & Africa Anti-Viral Drugs Sales by Country (2016-2021e) & (K Units)
Table 93. Middle East & Africa Anti-Viral Drugs Sales by Country (2021-2026) & (K Units)
Table 94. Middle East & Africa Anti-Viral Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 95. Middle East & Africa Anti-Viral Drugs Revenue by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Anti-Viral Drugs Sales by Type (2016-2021e) & (K Units)
Table 97. Middle East & Africa Anti-Viral Drugs Sales by Type (2021-2026) & (K Units)
Table 98. Middle East & Africa Anti-Viral Drugs Sales by Application (2016-2021e) & (K Units)
Table 99. Middle East & Africa Anti-Viral Drugs Sales by Application (2021-2026) & (K Units)
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Anti-Viral Drugs Typical Distributors
Table 103. Anti-Viral Drugs Typical Customers
List of Figures
Figure 1. Anti-Viral Drugs Picture
Figure 2. Global Anti-Viral Drugs Sales Market Share by Type in 2020
Figure 3. Nucleotide Polymerase Inhibitor
Figure 4. Reverse Transcriptase Inhibitor
Figure 5. Protease Inhibitor
Figure 6. Global Anti-Viral Drugs Sales Market Share by Application in 2020
Figure 7. HIV
Figure 8. Hepatitis
Figure 9. HSV
Figure 10. Influenza
Figure 11. Global Anti-Viral Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 12. Global Anti-Viral Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Anti-Viral Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Anti-Viral Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Anti-Viral Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Anti-Viral Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Anti-Viral Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Anti-Viral Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Anti-Viral Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Anti-Viral Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Anti-Viral Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Anti-Viral Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Anti-Viral Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Anti-Viral Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Anti-Viral Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Anti-Viral Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Anti-Viral Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Anti-Viral Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Anti-Viral Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Anti-Viral Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Anti-Viral Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Anti-Viral Drugs Sales (2016-2026) & (K Units)
Figure 33. Global Anti-Viral Drugs Production Capacity (2016-2026) & (K Units)
Figure 34. Global Anti-Viral Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Anti-Viral Drugs Market Drivers
Figure 36. Anti-Viral Drugs Market Restraints
Figure 37. Anti-Viral Drugs Market Trends
Figure 38. Global Anti-Viral Drugs Sales Market Share by Manufacturer in 2020
Figure 39. Global Anti-Viral Drugs Revenue Market Share by Manufacturer in 2020
Figure 40. Anti-Viral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Anti-Viral Drugs Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Anti-Viral Drugs Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Anti-Viral Drugs Sales Market Share by Region (2016-2026)
Figure 44. Global Anti-Viral Drugs Revenue Market Share by Region (2016-2026)
Figure 45. North America Anti-Viral Drugs Revenue (2016-2026) & (USD Million)
Figure 46. Europe Anti-Viral Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Anti-Viral Drugs Revenue (2016-2026) & (USD Million)
Figure 48. South America Anti-Viral Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Anti-Viral Drugs Revenue (2016-2026) & (USD Million)
Figure 50. Global Anti-Viral Drugs Sales Market Share by Type (2016-2026)
Figure 51. Global Anti-Viral Drugs Revenue Market Share by Type (2016-2026)
Figure 52. Global Anti-Viral Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 53. Global Anti-Viral Drugs Sales Market Share by Application (2016-2026)
Figure 54. Global Anti-Viral Drugs Revenue Market Share by Application (2016-2026)
Figure 55. Global Anti-Viral Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 56. North America Anti-Viral Drugs Sales Market Share by Country (2016-2026)
Figure 57. North America Anti-Viral Drugs Revenue Market Share by Country (2016-2026)
Figure 58. North America Anti-Viral Drugs Sales Market Share by Type (2016-2026)
Figure 59. North America Anti-Viral Drugs Sales Market Share by Application (2016-2026)
Figure 60. Europe Anti-Viral Drugs Sales Market Share by Country (2016-2026)
Figure 61. Europe Anti-Viral Drugs Revenue Market Share by Country (2016-2026)
Figure 62. Europe Anti-Viral Drugs Sales Market Share by Type (2016-2026)
Figure 63. Europe Anti-Viral Drugs Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Anti-Viral Drugs Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Anti-Viral Drugs Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Anti-Viral Drugs Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Anti-Viral Drugs Sales Market Share by Application (2016-2026)
Figure 68. South America Anti-Viral Drugs Sales Market Share by Country (2016-2026)
Figure 69. South America Anti-Viral Drugs Revenue Market Share by Country (2016-2026)
Figure 70. South America Anti-Viral Drugs Sales Market Share by Type (2016-2026)
Figure 71. South America Anti-Viral Drugs Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Anti-Viral Drugs Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Anti-Viral Drugs Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Anti-Viral Drugs Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Anti-Viral Drugs Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界のアンチエイジング薬市場 2021：企業別、地域別、種類・用途別 The Anti-Ageing Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …- 世界の抗喘息薬市場 2021：企業別、地域別、種類・用途別 The Anti Asthma Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …
- 世界の抗てんかん薬市場 2021：企業別、地域別、種類・用途別 The Anti Epilepsy Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界の小児科用抗てんかん薬市場 2021：企業別、地域別、種類・用途別 The Anti-epileptic Drugs for Pediatrics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 世界の神経保護薬市場 2021：企業別、地域別、種類・用途別 The Neuroprotective Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…